Episode 278
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, we're speaking with Bernard Ravina, M.D., CEO at Vima Therapeutics, a company that emerged fr…
Published on 13 hours ago
Episode 277
We love to hear from our listeners. Send us a message.
On this week's episode — the last of our four-part series focused on South Florida — we catch up with Rich Daly, CEO at Catalyst Pharmaceuticals…
Published on 1 week ago
Episode 276
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech -- part three in a four part series recorded in-person at Catalyst Pharmaceuticals' Miami head…
Published on 2 weeks ago
Episode 275
We love to hear from our listeners. Send us a message.
In this week's episode of the Business of Biotech -- part two in a four-part series recorded in-person at Catalyst Pharmaceuticals' Miami headqu…
Published on 3 weeks ago
Episode 274
We love to hear from our listeners. Send us a message.
The Business of Biotech is on location in Miami this week! For the first episode in this four-part series on the biotech scene in South Florida,…
Published on 4 weeks ago
Episode 273
We love to hear from our listeners. Send us a message.
On this week's episode of the Business of Biotech, Rob Abbott, CEO of ISPOR, explains how startup and early-stage clinical drug development comp…
Published on 1 month ago
Episode 272
We love to hear from our listeners. Send us a message.
On this week's episode, Joel Latham, President and CEO at Incannex Healthcare, talks about developing cannabinoid and psychedelic combination th…
Published on 1 month, 1 week ago
Episode 271
We love to hear from our listeners. Send us a message.
On this week's episode, Lyle Small, Founder and CEO at Lahjavida, a dye drug conjugate start-up, talks about creating the famous color-changing …
Published on 1 month, 2 weeks ago
Episode 270
We love to hear from our listeners. Send us a message.
On the Business of Biotech this week, Sahir Ali, Ph.D., founder and general partner at Modi Ventures, a family office investing at the intersect…
Published on 1 month, 3 weeks ago
Episode 269
We love to hear from our listeners. Send us a message.
On this week's episode, Atul Deshpande, Ph.D., CEO at Immediate Therapeutics, talks about partnering with American cities to conduct clinical tr…
Published on 2 months ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate